Farther-Finance-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-14
Total Holdings
4,304
Total Value
3918135517
Accession Number
0001992825-25-000004
Form Type
13F-HR
Manager Name
Farther-Finance-Advisors
Data Enrichment
71% identified
3,043 identified1,261 unidentified

Holdings

4,304 positions • $3.9B total value
Manager:
Search and click to pin securities to the top
Page 212 of 216
HarborOne Bancorp, Inc.
Shares:1
Value:$10
% of Portfolio:0.0% ($10/$3.9B)
Y2066G138
Shares:93
Value:$10
% of Portfolio:0.0% ($10/$3.9B)
Q32 Bio Inc.
Shares:6
Value:$9
% of Portfolio:0.0% ($9/$3.9B)
Y6430L202
Shares:11
Value:$9
% of Portfolio:0.0% ($9/$3.9B)
46138E222
Shares:0
Value:$9
% of Portfolio:0.0% ($9/$3.9B)
OLAPLEX HOLDINGS, INC.
Shares:7
Value:$9
% of Portfolio:0.0% ($9/$3.9B)
Day One Biopharmaceuticals, Inc.
Shares:1
Value:$8
% of Portfolio:0.0% ($8/$3.9B)
Udemy, Inc.
Shares:1
Value:$8
% of Portfolio:0.0% ($8/$3.9B)
cbdMD, Inc.
Shares:25
Value:$8
% of Portfolio:0.0% ($8/$3.9B)
Quanterix Corp
Shares:1
Value:$7
% of Portfolio:0.0% ($7/$3.9B)
Workhorse Group Inc.
Shares:4
Value:$7
% of Portfolio:0.0% ($7/$3.9B)
Global Business Travel Group, Inc.
Shares:1
Value:$7
% of Portfolio:0.0% ($7/$3.9B)
PLIANT THERAPEUTICS, INC.
Shares:5
Value:$7
% of Portfolio:0.0% ($7/$3.9B)
GILAT SATELLITE NETWORKS LTD
Shares:1
Value:$6
% of Portfolio:0.0% ($6/$3.9B)
Digital Turbine, Inc.
Shares:2
Value:$6
% of Portfolio:0.0% ($6/$3.9B)
Adaptimmune Therapeutics PLC
Shares:20
Value:$5
% of Portfolio:0.0% ($5/$3.9B)
LIFETIME BRANDS, INC
Shares:1
Value:$5
% of Portfolio:0.0% ($5/$3.9B)
STANDARD BIOTOOLS INC.
Shares:5
Value:$5
% of Portfolio:0.0% ($5/$3.9B)
Caesarstone Ltd.
Shares:2
Value:$5
% of Portfolio:0.0% ($5/$3.9B)
25058X303
Shares:1
Value:$5
% of Portfolio:0.0% ($5/$3.9B)